121 related articles for article (PubMed ID: 20589654)
21. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
22. PALB2/FANCN: recombining cancer and Fanconi anemia.
Tischkowitz M; Xia B
Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436
[TBL] [Abstract][Full Text] [Related]
24. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
25. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
26. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
27. Fanconi anaemia genes and susceptibility to cancer.
Mathew CG
Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
[TBL] [Abstract][Full Text] [Related]
28. Familial Wilms tumor.
Ruteshouser EC; Huff V
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
30. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
[TBL] [Abstract][Full Text] [Related]
31. The FANCA gene in Japanese Fanconi anemia: reports of eight novel mutations and analysis of sequence variability.
Tachibana A; Kato T; Ejima Y; Yamada T; Shimizu T; Yang L; Tsunematsu Y; Sasaki MS
Hum Mutat; 1999; 13(3):237-44. PubMed ID: 10090479
[TBL] [Abstract][Full Text] [Related]
32. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
33. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.
Barroso E; Pita G; Arias JI; Menendez P; Zamora P; Blanco M; Benitez J; Ribas G
Breast Cancer Res Treat; 2009 Dec; 118(3):655-60. PubMed ID: 19536649
[TBL] [Abstract][Full Text] [Related]
34. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
35. Two common founder mutations of the fanconi anemia group G gene FANCG/XRCC9 in the Japanese population.
Yagasaki H; Oda T; Adachi D; Nakajima T; Nakahata T; Asano S; Yamashita T
Hum Mutat; 2003 May; 21(5):555. PubMed ID: 12673805
[TBL] [Abstract][Full Text] [Related]
36. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
[TBL] [Abstract][Full Text] [Related]
37. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
[TBL] [Abstract][Full Text] [Related]
39. Fanconi Anaemia, Childhood Cancer and the
Woodward ER; Meyer S
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680915
[TBL] [Abstract][Full Text] [Related]
40. Screening Fanconi anemia lymphoid cell lines of non-A, C, D2, E, F, G subtypes for defects in BRCA2/FANCD1.
Popp H; Kalb R; Fischer A; Lobitz S; Kokemohr I; Hanenberg H; Schindler D
Cytogenet Genome Res; 2003; 103(1-2):54-7. PubMed ID: 15004464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
